Benefits
Patient Benefits
- Improved Quality of Life
- Reduced Hospitalization
- Reduced Surgery and Morbidity
- Preservation of Vascular Access Sites
- Improved Dialysis Efficiency
Dialysis Staff Benefits
- Empowered to identify and reduce access dysfunction and failure
- Provides valuable information for Continuous Quality Improvement (CQI) Programs
- Reduced emergencies due to access failure and under dialysis
Dialysis Clinic and Adminstrator Benefits
- Increases revenue through a reduction in missed dialysis treatments
- Improves outcomes for Continuous Quality Improvement (CQI) Programs
- Increases staff efficiency by reducing time spent on access failures and referals
- Competitive advantage that can be used to recruit patients
Insurance Provider Benefits
- Less costly interventions and hospitalizations due to access failure
- Overall reduction in dialysis care spending
There is an epidemic among hemodialysis patients.
It is the leading cause of death and morbidity in
patients with end-stage renal disease (ESRD)2-3.
It accounts for half of dialysis patient deaths and
a third of patient hospitalizations.4
And it is not being monitored very well.
Cardiovascular disease (CVD) is wreaking havoc
on ESRD patients—both during their hemodialysis
treatments and during their time away from clinics.
“In addition, cardiovascular collapse is a major
cause of complications during hemodialysis
treatments.”5
Congestive heart failure (CHF)
in ESRD patients results from cardiac overload,
anemia, severe hypertension and cardiac
dysfunction. CVD mortality rates are approximately
30 times that of the general population,4
and in
adolescents, CVD mortality rates are over 1,000
times that of their age-related peers.
A New Standard for ESRD Care
A new standard of care for ESRD patients emerged with introduction of the Transonic HD03 Hemodialysis Monitor a decade ago through groundbreaking ultrasound dilution technology. Flow-QC vascular access patency and dialysis adequacy monitoring, endorsed by the National Kidney Foundation’s K/DOQI Guidelines, has become routine in dialysis clinics around the world. Transonic Flow-QC Hemodialysis surveillance improves the quality of care for ESRD patients who experience less access discomfort, dysfunction and fewer access failures. Patients become empowered to assume responsibility for their vascular accesses, their link to life, and miss fewer dialysis treatments. Less expensive out-patient procedures correct deteriorating accesses and replace costly hospitalizations for failed vascular accesses.
